neladenoson bialanate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for neladenoson bialanate, covering 2019-04-23 to 2019-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction [Phase 2]